Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. ALDX
ALDX logo

ALDX Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Aldeyra Therapeutics Inc (ALDX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
2.230
1 Day change
-2.19%
52 Week Range
6.170
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

ALDX is not a good immediate buy for a beginner long-term investor with $50,000-$100,000 who is unwilling to wait. The stock has some short-term technical strength, but the overall setup is not strong enough to justify a direct buy right now. Best action: hold and wait for a better confirmation or a clearer fundamental catalyst.

Technical Analysis

ALDX closed at 2.35 after a weak regular-session move, though the price remains slightly above the reference current price of 2.27. MACD histogram is positive and expanding, which is constructive, but RSI_6 at 66.53 is near upper-neutral and not a strong buy signal. Moving averages are converging, suggesting indecision rather than a clean trend. Key levels show pivot at 2.095, resistance at 2.408 and 2.601, with support at 1.781 and 1.588. The stock pattern model points to downside drift over the next day, week, and month, which weakens the case for an immediate long-term entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options positioning is strongly bullish on paper, with very low put-call ratios in both open interest and volume, meaning call activity dominates. However, today’s option volume is very light, and the stock has no AI Stock Picker or SwingMax buy signal today. High implied volatility at 229.51 also suggests the market is pricing in large moves, but the current option flow looks more like speculative upside betting than a confirmed institutional bullish setup.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
5
Buy
6

Positive Catalysts

  • ["Positive MACD momentum with histogram expanding above zero", "Options sentiment is strongly call-skewed, indicating bullish speculation", "No recent negative news in the past week", "Post-market price change was positive at 3.53%, suggesting some late-session rebound interest"]

Neutral/Negative Catalysts

  • ["No news catalysts in the last week", "No recent congress trading data", "Hedge funds and insiders are both neutral with no notable accumulation", "No AI Stock Picker signal and no recent SwingMax signal", "Historical pattern analysis indicates negative expected returns over the next week and month", "RSI is not giving a strong breakout confirmation", "Financial snapshot is unavailable, so there is no fresh quarterly growth support"]

Financial Performance

Latest quarter financial data was not available due to a snapshot error, so there is no confirmed read on recent revenue or earnings growth trends. Because the latest quarter season cannot be verified from the provided data, there is not enough financial evidence here to support a long-term beginner-friendly buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend data was provided, so Wall Street sentiment cannot be confirmed from upgrades or target changes. Based on the available data, the analyst view appears neutral rather than strongly bullish, with no visible pro-upgrade or target-raise momentum.

Wall Street analysts forecast ALDX stock price to rise
2 Analyst Rating
Wall Street analysts forecast ALDX stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 2.280
sliders
Low
9
Averages
9.5
High
10
Current: 2.280
sliders
Low
9
Averages
9.5
High
10
H.C. Wainwright
Matthew Caufield
Buy -> Neutral
downgrade
$10 -> $2
AI Analysis
2026-03-18
Reason
H.C. Wainwright
Matthew Caufield
Price Target
$10 -> $2
AI Analysis
2026-03-18
downgrade
Buy -> Neutral
Reason
H.C. Wainwright analyst Matthew Caufield downgraded Aldeyra to Neutral from Buy with a price target of $2, down from $10, after the company received a complete response letter from the FDA related to reproxalap for the topical treatment of the signs and symptoms of dry eye disease. The firm reduced its probability of success for reproxalap from 75% to 40% and downgraded Aldeyra.

People Also Watch